Почетна › Глиобластом › Њујорк
Kliničke studije za Глиобластом u državi Њујорк
33 studija za Глиобластом traži učesnike na lokacijama u državi Њујорк.
Gradovi u državi Њујорк
- New York City30 студија
- Queens5 студија
- Staten Island3 студија
- New Rochelle3 студија
- Greenburgh3 студија
- Buffalo3 студија
Zvanični tekst studije (na engleskom)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
- Columbia University Irving Medical Center, New York
- Montefiore Medical Center, The Bronx
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07326566Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- NYU Langone Health, New York
Тражи се учесник
Узраст од 18 до 85 · Оба пола · Ажурирано 12. 11. 2026. · NCT06910306A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Icahn School of Medicine at Mount Sinai - Oncology, New York
- Memorial Sloan Kettering Cancer Center New York - Main Campus, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06914128Observational Connectomics in Adults Undergoing Resection of WHO II-IV Glioma
- Lenox Hill Brain Tumor Center, New York
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07927595Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Westchester Medical Center, Valhalla
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07195591Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT05432804A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- NYU Langone Health, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07464925A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center*, New York
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT03970447A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Lenox Hill Hospital, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT05303467A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- New York University Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05765812Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06860594Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06810544SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT05303519TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma
- Dent Neurologic Institute, Buffalo
Тражи се учесникФаза 1
Узраст од 18 до 80 · Оба пола · Ажурирано 9. 10. 2026. · NCT07862647Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- New York University Langone's Perlmutter Cancer Institute, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT06991101ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07089641Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Montefiore Medical Center-Einstein Campus, The Bronx
- Montefiore Medical Center-Weiler Hospital, The Bronx
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT07452458Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2026. · NCT06934889INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- Memorial Sloan Kettering Cancer Center, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT02977780Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
- Albany Medical Center, Albany
- Dent Neurologic Institute, Buffalo
- Northwell Health, Long Island City
- и још 4
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 17. 7. 2026. · NCT07225621DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- Lenox Hill Hospital, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT06805305A Study of 177Lu-PSMA-617 in People With Gliomas
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 6. 2026. · NCT07223034Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
- Lenox Hill Brain Tumor Center, New York
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 1. 6. 2026. · NCT05979064Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- Lenox Hill Brain Tumor Center, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 1. 6. 2026. · NCT02861898Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- Lenox Hill Brain Tumor Center, New York
Тражи се учесникФаза 1/2
Узраст од 18 до 74 · Оба пола · Ажурирано 1. 6. 2026. · NCT03213002Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- Lenox Hill Brain Tumor Center, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 1. 6. 2026. · NCT05271240Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
- Lenox Hill Brain Tumor Center, New York
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 1. 6. 2026. · NCT05954858Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- Lenox Hill Brain Tumor Center, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 1. 6. 2026. · NCT01269853Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- Lenox Hill Brain Tumor Center, New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT02800486Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 23. 2. 2026. · NCT06058988Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
- Stony Brook University Hospital, Stony Brook
Тражи се учесникРана фаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 12. 2025. · NCT05423210SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- и још 2
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
- Columbia University Medical Center - Herbert Irving Pavilion, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 25. 6. 2025. · NCT05879367Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.